Analysis of Factors Related to Pulmonary Nodules in Patients With Fatty Liver: A Large-Scale Cohort Study Based on a Physical Examination Population

Int J Gen Med. 2025 Jan 16:18:247-260. doi: 10.2147/IJGM.S495396. eCollection 2025.

Abstract

Purpose: People with fatty liver are at high risk for pulmonary nodules, but the underlying mechanism is unclear. This study aimed to investigate the occurrence of lung nodules in fatty liver patients and explore influencing factors.

Patients and methods: We retrospectively analyzed 57,119 individuals who underwent health checkups at the People's Hospital of Guangxi from May 2020 to May 2024. Patients with fatty liver were divided into pulmonary nodule and no pulmonary nodule groups. Univariate and multifactorial analyses were conducted using physical examination data, laboratory test indexes, and imaging information. Logistic regression analysis was used to identify independent predictors of pulmonary nodules in fatty liver patients.

Results: A total of 20,042 patients with fatty liver were included in the study, with 12,334 (61.5%) in the lung nodule group and 7708 (38.5%) in the non-lung nodule group. Age, gender, systolic and diastolic blood pressure were significantly higher in the pulmonary nodule group, while body weight, waist circumference, hemoglobin, uric acid, and glutamyltransferase were lower. Multifactorial logistic regression analysis showed that male gender, body weight, age, and diastolic blood pressure were significant factors influencing lung nodule development in fatty liver patients.

Conclusion: Fatty liver disease is independently associated with an increased incidence of pulmonary nodules, highlighting its importance in lung cancer screening and prevention.

Keywords: fatty liver; health checkup; influencing factors; pulmonary nodules; retrospective cohort study.

Grants and funding

This work was supported by the Guangxi Key Research and Development Program “Construction and Application of a Multidisciplinary Health Intervention System for Early Lung Cancer Screening in the Guangxi Health Examination Population” (Guike AB22080094) and the Research on the Construction and Application of a Health Intervention System for Early Lung Cancer Screening, a subject of the Guangxi Medical and Health Appropriate Technology Development and Promotion and Application (S2021035).